Immune Therapeutics, Inc.
IMUN · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $3 |
| SG&A Expenses | $1 | $1 | $1 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $3 |
| Operating Income | -$1 | -$1 | -$1 | -$3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | $4 | $2 | -$1 |
| Pre-Tax Income | -$4 | $4 | $2 | -$3 |
| Tax Expense | $2 | $0 | $0 | $1 |
| Net Income | -$6 | $4 | $1 | -$5 |
| % Margin | – | – | – | – |
| EPS | -0.16 | 7.41 | 2.4 | -10.44 |
| % Growth | -102.2% | 208.8% | 123% | – |
| EPS Diluted | -0.16 | 0.38 | 2.4 | -10.44 |
| Weighted Avg Shares Out | 36 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 36 | 9 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $1 | $3 | -$0 | $0 |
| EBITDA | -$1 | $2 | -$1 | -$2 |
| % Margin | – | – | – | – |